LifePoint Health, Inc. -- Moody's assigns Ba2 rating to LifePoint's unsecured note offering; Ba2 CFR unchanged; outlook is stable

New York, November 19, 2015 -- Moody's Investors Service assigned a Ba2 rating to $300 million of proposed senior unsecured notes being offered by LifePoint Health, Inc. The company intends to use proceeds from the issuance to fund acquisitions and for general corporate purposes, including the repurchase of common stock. Moody's estimates that pro-forma leverage will increase to about 3.7 times initially. Therefore, LifePoint's existing ratings, including the Ba2 Corporate Family Rating and the Ba2-PD Probability of Default Rating remain unchanged. The rating outlook is stable.

Vollständigen Artikel bei Moodys lesen